The world’s largest scientific society honored Sue B. Clark, a PNNL and WSU chemist, for contributions toward resolving our legacy of radioactive waste, advancing nuclear safeguards, and developing landmark nuclear research capabilities.

The researchers treated human pancreatic islets with substances produced by the body and thought to be involved in the diabetes disease process.

While it’s one small step forward for mouse research, it’s a big step forward for understanding proteins, the molecular workhorses in biological organisms.

PNNL’s Nuclear Process Science Initiative (NPSI) has developed a book that examines processes used to separate nuclear materials.

WSU recently announced James Boncella will lead the WSU-PNNL Nuclear Science and Technology Institute.

PNNL and Argonne researchers developed and tested a chemical process that successfully captures radioactive byproducts from used nuclear fuel so they could be sent to advanced reactors for destruction while also producing electrical power.

A new drug delivery method designed by researchers at PNNL and Washington State University (WSU) has shown it can target and kill lung cancer cells.

A gathering of international experts in Portland, Oregon, explored the future of electron microscopy and surfaced potential solutions in areas including new instrument designs, high-speed detectors, and data analytics capabilities.

A multi-institute team develops an imaging method that reveals how uranium dioxide (UO2) reacts with air. This could improve nuclear fuel development and opens a new domain for imaging the group of radioactive elements known as actinides.

The ANS award will be presented at the Global Top Fuel 2019 Conference this September in Seattle, and comes amid several recent recognitions for Paviet.

The first phase, which started in 2014, generated foundational data from developing mouse and human lungs, created a web portal for public data sharing, and established a repository of human lung tissues.

When two powerful earthquakes rocked southern California earlier this month, officials’ attention focused, understandably, on safety. How many people were injured? Were buildings up to code? How good are we at predicting earthquakes?

Researchers apply numerical simulations to understand more about a sturdy material and how its basic structure responds to and resists radiation. The outcomes could help guide development of the resilient materials of the future.

Scientists have taken one of the most detailed looks ever at levels of soluble amyloid beta in the brain.

PNNL scientist Wei-Jun Qian and colleagues have contributed to a study that offers clues for delaying or even preventing the autoimmune attack that’s at the core of type-1 diabetes.

PNNL researchers today published a pair of papers, in Cell and in Nature, exploring the effects of the gut microbiome on our health, including autism, brain function, and inflammatory bowel disease.

He is being recognized for his contributions involving various kinds of separations with mass spectrometry (MS).

His patents involve novel MS and IMS technologies that, in the end, have enabled a deeper understanding of living systems.

PNNL researchers have devised a way to measure and distinguish tiny amounts of phosphorylated proteins, an approach that could be used in research to help treat diseases such as diabetes and cancer.

The structure of a fundamental electrical switch in the brain has been revealed, thanks to PNNL researchers working together with counterparts at Oregon Health & Science University (OHSU).